Post-approval studies (Phase 4)Study completedNCT02495324What this trial is testingFimasartan Achieving SBP Target (FAST) StudyWho this might be right forEssential,Hypertension Boryung Pharmaceutical Co., Ltd 369
Testing effectiveness (Phase 2)Study completedNCT02222480What this trial is testingA Clinical Trial to Evaluate Efficacy, Tolerability, and Pharmacokinetic-Pharmacodynamic Relationship of Fimasartan/HydrochlorothiazideWho this might be right forHypertension Boryung Pharmaceutical Co., Ltd 103
Post-approval studies (Phase 4)Study completedNCT00302705What this trial is testingComparison of the Antihypertensive Efficacy of Valsartan and Enalapril After Missing One DoseWho this might be right forHypertension University of Vigo 150
Large-scale testing (Phase 3)Study completedNCT01631227What this trial is testingComparison of the Effect of Eprosartan and Eprosartan Mesylate on Blood Pressure in Essential HypertensionWho this might be right forEssential Hypertension Abbott 665
Testing effectiveness (Phase 2)Study completedNCT00710372What this trial is testingSafety, Tolerability and Efficacy of a Vaccine Against Essential HypertensionWho this might be right forMild Essential HypertensionModerate Essential Hypertension Cytos Biotechnology AG 83
Testing effectiveness (Phase 2)UnknownNCT05033535What this trial is testingS086 Tablets in the Treatment of Mild to Moderate Essential HypertensionWho this might be right forEssential Hypertension Shenzhen People's Hospital 10
Large-scale testing (Phase 3)Study completedNCT02206659What this trial is testingEffects of Telmisartan by Ambulatory Blood Pressure Monitoring (ABPM) in Chinese Patients With Mild to Moderate Essential HypertensionWho this might be right forHypertension Boehringer Ingelheim 20
Testing effectiveness (Phase 2)Study completedNCT01303783What this trial is testingStudy of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential HypertensionWho this might be right forHypertension, Essential Bayer 1,381
Large-scale testing (Phase 3)Study completedNCT00857285What this trial is testingOlmesartan Medoxomil Versus Losartan in Patients With HypertensionWho this might be right forEssential Hypertension Daiichi Sankyo 130
Large-scale testing (Phase 3)Study completedNCT00257491What this trial is testingStudy to Evaluate the Trough and Peak Effect of Once Daily Telmisartan 80 mg/Hydrochlorothiazide 12.5 mg (Micardis Plus) by Ambulatory Blood Pressure Monitoring (ABPM) in Patients With Mild to Moderate Essential HypertensionWho this might be right forHypertension Boehringer Ingelheim 29
Testing effectiveness (Phase 2)Study completedNCT03756103What this trial is testingSafety and Efficacy of SPH3127 on Treating Mild-moderate Essential Hypertension PatientsWho this might be right forHypertension,Essential Shanghai Pharmaceuticals Holding Co., Ltd 120
Post-approval studies (Phase 4)Study completedNCT00328965What this trial is testingLacidipine In Mild To Moderate Essential Hypertension Patients With Type 2 Diabetes In KoreaWho this might be right forDiabetes Mellitus, Type 2Essential Hypertension GlaxoSmithKline
Large-scale testing (Phase 3)Not Yet RecruitingNCT06771245What this trial is testingA Phase III Clinical Trial Evaluating the Efficacy and Safety of Valsartan/Levamlodipine (SYH9056) Tablets In Hypertensive PatientsWho this might be right forMild-to-moderate Essential Hypertension CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 606
Large-scale testing (Phase 3)WithdrawnNCT02969265What this trial is testingAn Efficacy and Safety Study Evaluating the Fixed-Dose Combination of Candesartan Plus Amlodipine in Participants With Mild/Moderate Essential HypertensionWho this might be right forHypertension Takeda
Post-approval studies (Phase 4)Study completedNCT00765947What this trial is testingEfficacy and Tolerability of an Aliskiren-based Treatment Algorithm in Patients With Mild to Moderate HypertensionWho this might be right forEssential Hypertension ( Mild to Moderate) Novartis 256
Testing effectiveness (Phase 2)Study completedNCT00922441What this trial is testingA Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan (BR-A-657•K) During 24 Hours in Patients With Mild to Moderate Essential HypertensionWho this might be right forEssential Hypertension Boryung Pharmaceutical Co., Ltd 92
Large-scale testing (Phase 3)Study completedNCT00185172What this trial is testingOlmesartan in Essential HypertensionWho this might be right forEssential Hypertension Sankyo Pharma Gmbh 2,333
Post-approval studies (Phase 4)UnknownNCT02641821What this trial is testingEffect of Nifedipine GITS in Patients With Mild-to-moderate Primary HypertensionWho this might be right forHypertension Peking University First Hospital 700
Testing effectiveness (Phase 2)Study completedNCT01281306What this trial is testingAn 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic HypertensionWho this might be right forSystolic Hypertension Novartis Pharmaceuticals 910
Post-approval studies (Phase 4)Study completedNCT01431508What this trial is testingSafety and Efficacy in MK-0954A Combination in Participants With Hypertension (MK-0954A-373 AM3)Who this might be right forHypertension Organon and Co 15